![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » JORDAN REMAINS NET DRUG EXPORTER AS MODERNISATION CONTINUES
JORDAN REMAINS NET DRUG EXPORTER AS MODERNISATION CONTINUES
September 8, 2005
Jordan's drug exports have continued to outstrip imports in the first half of 2005. A painful consolidation process in the domestic industry and a small local market has made the export sector an increasingly attractive option for local manufacturers.
Drug exports grew from JOD82.8mn (US$116.81mn) last year to JOD96.5mn (US$136.16mn) in the first half of 2005. Jordan has been a net exporter of medicines since 2001, and foreign sales could be boosted by the country's World Trade Organization (WTO) accession.
Jordan's drug imports accounted for approximately 74% of the market in 2004, with foreign pharmaceuticals worth JOD87.6mn (US$123.63mn) in the first half of 2005, according to official statistics. This compares with JOD78.1mn (US$110.23mn) for the same period in 2004. Import growth has been driven by a growing demand for novel therapies, and better access in the wake of the US-Jordan Free Trade Agreement, signed in 2000.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct